Kairos Pharma (KAPA) EBIT

Annual EBIT

-$1.77 M
-$771.00 K-77.18%

December 1, 2023


Summary


Performance

KAPA EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherKAPAprofitabilitymetrics:

Quarterly EBIT

-$920.00 K
-$679.00 K-281.74%

September 30, 2024


Summary


Performance

KAPA Quarterly EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherKAPAprofitabilitymetrics:

TTM EBIT

-$2.58 M
-$623.00 K-31.79%

September 30, 2024


Summary


Performance

KAPA TTM EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherKAPAprofitabilitymetrics:

EBIT Formula

EBIT = Revenue − COGS − Operating Expenses

KAPA EBIT Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-77.2%0.0%0.0%
3 y3 years-69.2%0.0%0.0%
5 y5 years-69.2%0.0%0.0%

KAPA EBIT Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-77.2%+16.7%-576.5%+17.5%-1048.0%at low
5 y5-year-77.2%+16.7%-576.5%+17.5%-1048.0%at low
alltimeall time-77.2%+16.7%-576.5%+17.5%-1048.0%at low

Kairos Pharma EBIT History

DateAnnualQuarterlyTTM
Sep 2024
-
-$920.00 K(+281.7%)
-$2.58 M(+31.8%)
Jun 2024
-
-$241.00 K(-21.5%)
-$1.96 M(+1.0%)
Mar 2024
-
-$307.00 K(-72.5%)
-$1.94 M(+9.7%)
Dec 2023
-$1.77 M
-$1.11 M(+275.4%)
-$1.77 M(+109.5%)
Sep 2023
-
-$297.00 K(+33.8%)
-$845.00 K(+10.9%)
Jun 2023
-
-$222.00 K(+63.2%)
-$762.00 K(-16.3%)
DateAnnualQuarterlyTTM
Mar 2023
-
-$136.00 K(-28.4%)
-$910.00 K(-8.9%)
Dec 2022
-$999.00 K(-53.0%)
-$190.00 K(-11.2%)
-$999.00 K(+23.5%)
Sep 2022
-
-$214.00 K(-42.2%)
-$809.00 K(+36.0%)
Jun 2022
-
-$370.00 K(+64.4%)
-$595.00 K(+164.4%)
Mar 2022
-
-$225.00 K
-$225.00 K
Dec 2021
-$2.13 M(+103.2%)
-
-
Dec 2020
-$1.05 M
-
-

FAQ

  • What is Kairos Pharma annual earnings before interest & taxes?
  • What is the all time high annual EBIT for Kairos Pharma?
  • What is Kairos Pharma annual EBIT year-on-year change?
  • What is Kairos Pharma quarterly earnings before interest & taxes?
  • What is the all time high quarterly EBIT for Kairos Pharma?
  • What is Kairos Pharma quarterly EBIT year-on-year change?
  • What is Kairos Pharma TTM earnings before interest & taxes?
  • What is the all time high TTM EBIT for Kairos Pharma?
  • What is Kairos Pharma TTM EBIT year-on-year change?

What is Kairos Pharma annual earnings before interest & taxes?

The current annual EBIT of KAPA is -$1.77 M

What is the all time high annual EBIT for Kairos Pharma?

Kairos Pharma all-time high annual earnings before interest & taxes is -$999.00 K

What is Kairos Pharma annual EBIT year-on-year change?

Over the past year, KAPA annual earnings before interest & taxes has changed by -$771.00 K (-77.18%)

What is Kairos Pharma quarterly earnings before interest & taxes?

The current quarterly EBIT of KAPA is -$920.00 K

What is the all time high quarterly EBIT for Kairos Pharma?

Kairos Pharma all-time high quarterly earnings before interest & taxes is -$136.00 K

What is Kairos Pharma quarterly EBIT year-on-year change?

Over the past year, KAPA quarterly earnings before interest & taxes has changed by $0.00 (0.00%)

What is Kairos Pharma TTM earnings before interest & taxes?

The current TTM EBIT of KAPA is -$2.58 M

What is the all time high TTM EBIT for Kairos Pharma?

Kairos Pharma all-time high TTM earnings before interest & taxes is -$225.00 K

What is Kairos Pharma TTM EBIT year-on-year change?

Over the past year, KAPA TTM earnings before interest & taxes has changed by $0.00 (0.00%)